![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, December 28, 2014 7:42:43 AM
I spoke to an Analyst at one of the leading investment boutique firms in NYC (who covers small bio's). He routinely speaks to Gerald from time to time; he reminded me that the ESS trial start up has unique attributes because its not a drug compound that carries a lot of risk. Most importantly, he said once the trial starts up; the market cap alone should be increased by at least $150-$180mm (and Wall street will heed notice once the firm is Up listed).
Overall, the incremental dilution (more recent) is minor in relation to the quality assets that Gerald (and management) have been acquiring lately and of whats most important is the true underlying valuation (so watch what happens to the Market cap in 2015....you will be pleasantly surprised).
Note: Sorry Solantey; you last chance to acquire the PPS much cheaper are behind you. Just recognize that you cant stop a tidal wave that's starting to begin and in motion; just jump on and go for the ride.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM